The study, titled “Oral Supplementation with Baker’s Yeast Beta Glucan Is Associated with Altered Monocytes, T Cells and Cytokines Following a Bout of Strenuous Exercise,” was published in Frontiers in Physiology, a journal publishing peer-reviewed research on the physiological functions of living systems.
Using exercise stress to modulate the immune system, the study examined the effects of the proprietary baker’s yeast beta glucan on immune function during and after exercise. Results showed that Wellmune-consuming participants maintained elevated levels of cytokines during exercise stress and superior recovery capability when compared to participants taking a placebo. Participants taking Wellmune also had a significantly higher number of monocytes and T-cells circulating in the blood than those consuming a placebo. These results suggest that participants’ immune systems were able to avoid common post-exercise suppression when supported by Wellmune.
“Immediately after vigorous exercise, the strength of the body’s immune system is reduced, making both trained athletes and ‘weekend warriors’ more prone to illness,” said Donald Cox, PhD, Kerry’s director of R&D for Wellmune. “The positive results from this study are critical indicators that taking Wellmune can help strengthen the immune systems of active adults undergoing high physical stress.”
Findings from the new study are consistent with other published studies that show Wellmune is clinically proven to help improve general immune health, reduce the incidence of upper respiratory tract infection symptoms, and improve the overall sense of well-being in people experiencing physical or lifestyle stress.
“Through our focus on clinical research, we are committed to providing an effective immune health ingredient that helps people live a quality life and supports their activate lifestyles,” continued Dr. Cox. “This study builds on already established clinical data that demonstrates Wellmune helps support our immune system throughout our life or lifestyle needs.”